ZNF207 in human diseases: Molecular mechanisms, signalling networks, and emerging therapeutic opportunities.
Mechanistically, ZNF207 contributes to tumour development and progression through modulation of major oncogenic signalling pathways, including phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin signalling, nuclear factor erythroid 2-related factor 2 (NRF2)-related ferroptosis, spindle checkpoint and immune-regulatory pathways.